Papers
6
Total Citations
48
H-Index
4
About
Dr. Charles C. Peyton is a urologic oncologist and surgeon-scientist whose research focuses on optimizing surgical outcomes for renal cell carcinoma and bladder cancer, with a particular emphasis on robotic-assisted techniques. His major contributions include defining the incidence, risk factors, and management of urinary leak after partial nephrectomy—a study of 975 patients that remains a cornerstone reference for postoperative care. He has also pioneered comparative effectiveness research, demonstrating that single-port robotic radical cystectomy offers comparable outcomes to multiport approaches while potentially reducing analgesic requirements. Dr. Peyton’s work on preoperative risk stratification is notable: he showed that simple urine dipstick proteinuria can predict de novo chronic kidney disease after robotic partial nephrectomy, enabling earlier intervention. His randomized controlled trial of sildenafil for renoprotection during hilar clamping represents a novel pharmacologic strategy to preserve renal function. With over 48 citations across his most-cited works, Dr. Peyton has also contributed to international collaborations comparing open, laparoscopic, and robotic approaches for tumor thrombectomy in advanced kidney cancer. His research directly informs clinical guidelines and surgical decision-making, bridging the gap between innovation and patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6